Junji Saruwatari

2.3k total citations
108 papers, 1.4k citations indexed

About

Junji Saruwatari is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, Junji Saruwatari has authored 108 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 20 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Junji Saruwatari's work include Pharmacogenetics and Drug Metabolism (19 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Liver Disease Diagnosis and Treatment (13 papers). Junji Saruwatari is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Liver Disease Diagnosis and Treatment (13 papers). Junji Saruwatari collaborates with scholars based in Japan, China and United States. Junji Saruwatari's co-authors include Kazuko Nakagawa, Kentaro Oniki, Ayami Kajiwara, Kazunori Morita, Norio Yasui‐Furukori, Takateru Ishitsu, Yoshiyuki Tsuda, Yasuhiro Ogata, Norio Yasui‐Furukori and Sunao Kaneko and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Junji Saruwatari

104 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Saruwatari Japan 22 259 249 244 230 220 108 1.4k
Kentaro Oniki Japan 20 227 0.9× 141 0.6× 80 0.3× 236 1.0× 163 0.7× 87 1.1k
Inge De Lepeleire United States 28 278 1.1× 237 1.0× 207 0.8× 186 0.8× 101 0.5× 80 2.4k
Michael J. Fossler United States 22 371 1.4× 85 0.3× 100 0.4× 123 0.5× 186 0.8× 69 1.5k
Chien-Hsiun Chen Taiwan 17 300 1.2× 59 0.2× 445 1.8× 303 1.3× 107 0.5× 41 1.4k
Minkyung Oh South Korea 19 137 0.5× 112 0.4× 128 0.5× 157 0.7× 91 0.4× 94 1.2k
Kazuyuki Inoue Japan 27 551 2.1× 473 1.9× 301 1.2× 318 1.4× 447 2.0× 96 2.3k
Brian M. Gilfix Canada 24 638 2.5× 200 0.8× 104 0.4× 146 0.6× 204 0.9× 59 2.1k
Shin Irie Japan 24 289 1.1× 114 0.5× 441 1.8× 246 1.1× 419 1.9× 89 1.9k
Dolores Ochoa Spain 25 207 0.8× 301 1.2× 548 2.2× 94 0.4× 273 1.2× 98 1.6k
Carlo Piccinni Italy 18 198 0.8× 222 0.9× 41 0.2× 235 1.0× 73 0.3× 91 1.2k

Countries citing papers authored by Junji Saruwatari

Since Specialization
Citations

This map shows the geographic impact of Junji Saruwatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Saruwatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Saruwatari more than expected).

Fields of papers citing papers by Junji Saruwatari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Saruwatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Saruwatari. The network helps show where Junji Saruwatari may publish in the future.

Co-authorship network of co-authors of Junji Saruwatari

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Saruwatari. A scholar is included among the top collaborators of Junji Saruwatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Saruwatari. Junji Saruwatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saruwatari, Junji, Tetsu Tomita, Shoko Tsuchimine, et al.. (2025). A MODELING APPROACH TO THE THERAPEUTIC EFFECT OF PAROXETINE FOR DEPRESSION WITH A FOCUS ON PHARMACOKINETICS- PHARMACODYNAMICS RELATIONSHIP. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i189–i190.
2.
Tomita, Tetsu, Miki Nishimura, Tetsuya Kaneko, et al.. (2025). Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic‐Pharmacodynamic and Machine Learning Analyses. CPT Pharmacometrics & Systems Pharmacology. 14(6). 1119–1127. 1 indexed citations
3.
Fukuda, Ryo, Yukio Fujiwara, Hitoshi Maeda, et al.. (2025). Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages. Molecular Cancer. 24(1). 132–132. 1 indexed citations
4.
Oniki, Kentaro, Masatsune Ogura, Hiroshi Watanabe, et al.. (2024). Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction. Journal of Atherosclerosis and Thrombosis. 31(8). 1149–1161. 2 indexed citations
5.
Oniki, Kentaro, Kayoko Ohura, Teruya Nakamura, et al.. (2024). The Association of the Cholesterol Efflux Capacity with the <i>Paraoxonase 1</i> Q192R Genotype and the Paraoxonase Activity. Journal of Atherosclerosis and Thrombosis. 31(9). 1263–1276. 2 indexed citations
6.
Saruwatari, Junji, Tetsuya Kaneko, Tsukasa Murata, et al.. (2024). Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice. Neuropsychopharmacology Reports. 44(3). 614–619. 1 indexed citations
7.
Tanaka, Masatake, Jain Jeong, Xuchen Zhang, et al.. (2023). The Sympathetic Nervous System Promotes Hepatic Lymphangiogenesis, which Is Protective Against Liver Fibrosis. American Journal Of Pathology. 193(12). 2182–2202. 3 indexed citations
8.
Ishida, Toshifumi, Yuichiro Arima, Yuji Mizuno, et al.. (2021). East Asian variant aldehyde dehydrogenase type 2 genotype exacerbates ischemia/reperfusion injury with ST-elevation myocardial infarction in men: possible sex differences. Heart and Vessels. 37(2). 184–193. 6 indexed citations
9.
Fukunaga, Masaki, Daisuke Kadowaki, Mika Mori, et al.. (2020). In vivo evaluation of drug dialyzability in a rat model of hemodialysis. PLoS ONE. 15(6). e0233925–e0233925. 4 indexed citations
10.
Inazumi, Tomoaki, Kiyotaka Yamada, Naritoshi Shirata, et al.. (2020). Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. Cell Reports. 33(2). 108265–108265. 42 indexed citations
11.
Oniki, Kentaro, Yuki Sakamoto, Tadashi Imafuku, et al.. (2020). The DsbA-L gene is associated with respiratory function of the elderly via its adiponectin multimeric or antioxidant properties. Scientific Reports. 10(1). 5973–5973. 13 indexed citations
12.
Nishimura, Miki, Junji Saruwatari, Akiko Aoki, et al.. (2016). Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder. Pharmacogenetics and Genomics. 26(9). 403–413. 2 indexed citations
13.
Oniki, Kentaro, Miki Nishimura, Kazuki Matsuda, et al.. (2015). Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. PLoS ONE. 10(10). e0141266–e0141266. 30 indexed citations
14.
15.
Tsuda, Yoshiyuki, Junji Saruwatari, & Norio Yasui‐Furukori. (2014). Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine. BMJ Open. 4(3). e004216–e004216. 76 indexed citations
16.
Morita, Kazunori, Hiroko Miyazaki, Junji Saruwatari, et al.. (2014). Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients. Toxicology Letters. 232(1). 221–225. 13 indexed citations
17.
Kajiwara, Ayami, Junji Saruwatari, Kentaro Oniki, et al.. (2013). Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy. Pharmacogenetics and Genomics. 23(12). 717–720. 9 indexed citations
18.
Oniki, Kentaro, Masaharu Hori, Junji Saruwatari, et al.. (2013). Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. Toxicology Letters. 220(2). 143–149. 19 indexed citations
19.
20.
Yamamoto, Koichiro, Seiji Hokimoto, Kazunori Morita, et al.. (2010). Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy. Journal of Cardiology. 57(2). 194–201. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Oniki Breakdown of academic impact, for papers by Inge De Lepeleire Breakdown of academic impact, for papers by Michael J. Fossler Breakdown of academic impact, for papers by Chien-Hsiun Chen Breakdown of academic impact, for papers by Minkyung Oh Breakdown of academic impact, for papers by Kazuyuki Inoue Breakdown of academic impact, for papers by Brian M. Gilfix Breakdown of academic impact, for papers by Shin Irie Breakdown of academic impact, for papers by Dolores Ochoa Breakdown of academic impact, for papers by Carlo Piccinni
Rankless by CCL
2026